Arabic Arabic English English French French German German
dark

Active Biotech’s partner NeoTX will host KOL webinar on overcoming check point Inhibitor resistance

Active Biotech provided information that its partner in the naptumomab project, NeoTX will host a key opinion leader webinar on overcoming checkpoint inhibitor resistance on Wednesday, July 14th at 10 am eastern time Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation.

Next Post

BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Esophageal Squamous Cell Carcinoma (ESCC)

Related Posts
Total
0
Share